2-(1-(3-ethoxy-4-methoxybenzyl)piperidin-4-ylamino)-N,N-dimethylbenzo[d]oxazole-5-sulfonamide

ID: ALA1078528

PubChem CID: 46882622

Max Phase: Preclinical

Molecular Formula: C24H32N4O5S

Molecular Weight: 488.61

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1cc(CN2CCC(Nc3nc4cc(S(=O)(=O)N(C)C)ccc4o3)CC2)ccc1OC

Standard InChI:  InChI=1S/C24H32N4O5S/c1-5-32-23-14-17(6-8-22(23)31-4)16-28-12-10-18(11-13-28)25-24-26-20-15-19(7-9-21(20)33-24)34(29,30)27(2)3/h6-9,14-15,18H,5,10-13,16H2,1-4H3,(H,25,26)

Standard InChI Key:  RMRBRTBXJMVAPE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    9.2966  -26.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2954  -27.8146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0128  -28.2275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0108  -26.5744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7243  -26.9831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7246  -27.8097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5112  -28.0627    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9995  -27.3959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5100  -26.7303    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8244  -27.3951    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2376  -28.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8261  -28.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2353  -29.5334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0606  -29.5373    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4747  -28.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0636  -28.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4709  -30.2556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2956  -30.2582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7031  -30.9708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5271  -30.9738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9427  -30.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5277  -29.5410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7051  -29.5420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9395  -28.8282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7644  -28.8277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1763  -28.1102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7676  -30.2634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1788  -30.9765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5825  -28.2265    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.1617  -28.9348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9865  -28.9348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8638  -27.8121    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8624  -26.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1475  -28.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  1  0
  6  7  1  0
 14 17  1  0
  7  8  2  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  9  5  1  0
 19 20  1  0
  4  1  1  0
 20 21  2  0
  8 10  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
 10 11  1  0
 22 24  1  0
 11 12  1  0
 24 25  1  0
 25 26  1  0
  2  3  1  0
 21 27  1  0
  3  6  2  0
 27 28  1  0
  1  2  2  0
  2 29  1  0
  5  4  2  0
 29 30  2  0
 11 16  1  0
 29 31  2  0
 12 13  1  0
 29 32  1  0
 13 14  1  0
 32 33  1  0
 14 15  1  0
 32 34  1  0
M  END

Associated Targets(Human)

SSTR5 Tclin Somatostatin receptor 5 (1477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR3 Tclin Somatostatin receptor 3 (1562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR4 Tclin Somatostatin receptor 4 (1125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.61Molecular Weight (Monoisotopic): 488.2093AlogP: 3.56#Rotatable Bonds: 9
Polar Surface Area: 97.14Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.49CX Basic pKa: 7.54CX LogP: 2.32CX LogD: 1.94
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.49Np Likeness Score: -1.72

References

1. Martin RE, Mohr P, Maerki HP, Guba W, Kuratli C, Gavelle O, Binggeli A, Bendels S, Alvarez-Sánchez R, Alker A, Polonchuk L, Christ AD..  (2009)  Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,  19  (21): [PMID:19786348] [10.1016/j.bmcl.2009.09.024]

Source